Nemaura Medical Inc.
Healthcare · Surgical & Medical Instruments & Apparatus · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | |
|---|---|---|---|---|---|---|
| Revenue | $77,044 | $503,906 | $0 | $0 | $0 | $0 |
| Operating income | −$9.6M | −$7.6M | −$4.6M | −$4.8M | −$4.5M | −$1.9M |
| Net income | −$14.1M | −$13.9M | −$6.3M | −$4.2M | −$4.5M | −$1.8M |
| Total assets | $14.6M | $22.1M | $35.2M | $1.2M | $4.8M | $6.3M |
| Total liabilities | $26.4M | $21.6M | $26.9M | $2.5M | $2.5M | $2.1M |
| Equity | −$11.8M | $466,084 | $8.4M | −$1.3M | $2.2M | $4.1M |
| EPS (diluted) | $-0.57 | $-0.59 | — | — | — | — |
| Shares out. | 28.9M | 24.1M | 23.3M | 21.0M | 208.0M | 205.0M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2023- Operating margin
- −12454.2%
- Net margin
- −18358.0%
- Return on equity
- 119.7%
- Return on assets
- −97.1%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 181.1%
- Debt / equity
- —
- Book value / share
- $-0.41
- Revenue growth (YoY)
- −84.7%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2023- Altman Z″ (distress)
- -20.44distress
- Accruals / assets
- −39.1%clean
- Piotroski F-Score
- 1/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 3 severe● 5 warning● 2 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Strong return on equity (>15%)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Jul 1, 2024
- NT 10-Kmissed a reporting deadline ↗Jun 29, 2023
- NT 10-Qmissed a reporting deadline ↗Feb 15, 2023
- NT 10-Kmissed a reporting deadline ↗Jun 14, 2017
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Director / officer change · Regulation FD disclosureSep 26, 2024
- Shareholder voteMay 17, 2024
- Amended charter or bylawsApr 22, 2024
- Entered a material agreement · Unregistered equity sale · Director / officer changeApr 10, 2024
- Shareholder voteFeb 26, 2024
- Delisting / listing-standard noticeJan 3, 2024
- Regulation FD disclosureJan 3, 2024
- Regulation FD disclosureDec 13, 2023
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 8-KFORM 8-KSep 26, 2024
- DEF 14CDEFINITIVE 14CJul 1, 2024
- NT 10-KFORM 12B-25Jul 1, 2024
- 8-KFORM 8-KMay 17, 2024
- 8-KFORM 8-KApr 22, 2024
- PRE 14CApr 19, 2024
- 8-KFORM 8-KApr 10, 2024
- 25-NSEMar 21, 2024
- 8-KFORM 8-KFeb 26, 2024
- SC 13GFeb 14, 2024
- 10-QFORM 10-QFeb 12, 2024
- DEFA14ADEFINITIVE 14A ADDTIONAL MATERIALSJan 17, 2024
- DEF 14ADEFINITIVE 14AJan 17, 2024
- 4Jan 9, 2024
- 3Jan 9, 2024
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.